BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17096012)

  • 1. A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia.
    Borriello A; Locasciulli A; Bianco AM; Criscuolo M; Conti V; Grammatico P; Cappellacci S; Zatterale A; Morgese F; Cucciolla V; Delia D; Della Ragione F; Savoia A
    Leukemia; 2007 Jan; 21(1):72-8. PubMed ID: 17096012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
    Reliene R; Yamamoto ML; Rao PN; Schiestl RH
    Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.
    Kalb R; Neveling K; Hoehn H; Schneider H; Linka Y; Batish SD; Hunt C; Berwick M; Callen E; Surralles J; Casado JA; Bueren J; Dasi A; Soulier J; Gluckman E; Zwaan CM; van Spaendonk R; Pals G; de Winter JP; Joenje H; Grompe M; Auerbach AD; Hanenberg H; Schindler D
    Am J Hum Genet; 2007 May; 80(5):895-910. PubMed ID: 17436244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
    Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
    Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fanconi anemia proteins FANCD2 and FANCJ interact and regulate each other's chromatin localization.
    Chen X; Wilson JB; McChesney P; Williams SA; Kwon Y; Longerich S; Marriott AS; Sung P; Jones NJ; Kupfer GM
    J Biol Chem; 2014 Sep; 289(37):25774-82. PubMed ID: 25070891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
    Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
    Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective FANCI binding by a fanconi anemia-related FANCD2 mutant.
    Sato K; Ishiai M; Takata M; Kurumizaka H
    PLoS One; 2014; 9(12):e114752. PubMed ID: 25489943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.
    Gordon SM; Buchwald M
    Blood; 2003 Jul; 102(1):136-41. PubMed ID: 12649160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.
    Lensch MW; Tischkowitz M; Christianson TA; Reifsteck CA; Speckhart SA; Jakobs PM; O'Dwyer ME; Olson SB; Le Beau MM; Hodgson SV; Mathew CG; Larson RA; Bagby GC
    Blood; 2003 Jul; 102(1):7-16. PubMed ID: 12637330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.
    Jeong E; Lee SG; Kim HS; Yang J; Shin J; Kim Y; Kim J; Schärer OD; Kim Y; Yeo JE; Kim HM; Cho Y
    Nucleic Acids Res; 2020 Apr; 48(6):3328-3342. PubMed ID: 32002546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal.
    Boisvert RA; Rego MA; Azzinaro PA; Mauro M; Howlett NG
    PLoS One; 2013; 8(11):e81387. PubMed ID: 24278431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygote FANCD2 mutations associated with childhood T Cell ALL and testicular seminoma.
    Smetsers S; Muter J; Bristow C; Patel L; Chandler K; Bonney D; Wynn RF; Whetton AD; Will AM; Rockx D; Joenje H; Strathdee G; Shanks J; Klopocki E; Gille JJ; Dorsman J; Meyer S
    Fam Cancer; 2012 Dec; 11(4):661-5. PubMed ID: 22829014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promyelocytic Leukemia Proteins Regulate Fanconi Anemia Gene Expression.
    Munkhjargal A; Kim MJ; Kim DY; Jeon YJ; Kee YH; Kim LK; Kim YH
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
    Taniguchi T; D'Andrea AD
    Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia.
    Behera CK; Gyandeep G; Mishra R; Mohanty RP; Pal A; Behera J; Samal S; Das B
    Mol Biol Rep; 2023 Jan; 50(1):931-936. PubMed ID: 36369330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.
    Wilson JB; Blom E; Cunningham R; Xiao Y; Kupfer GM; Jones NJ
    Mutat Res; 2010 Jul; 689(1-2):12-20. PubMed ID: 20450923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.
    Gallmeier E; Hucl T; Calhoun ES; Cunningham SC; Bunz F; Brody JR; Kern SE
    Cancer Biol Ther; 2007 May; 6(5):654-60. PubMed ID: 17387268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.